IKT Inhibikase Therapeutics Inc Com
0%
Previous Close
Open
52 Week Low
52 Week High
Market Cap
$0
Shares
9,605,251
Float
4,303,550
Enterprise Value
$0
Volume
0
Av. Daily Volume
0
Drug Pipeline
| Drug | Stage | Notes |
|---|---|---|
|
IkT-148009
Parkinson’s disease
|
Phase 1b
Phase 1b
|
Phase 1b trial to be initiated in 2021.
|